New study aims to boost survival for kids with Burkitt's lymphoma

NCT ID NCT04425421

Recruiting now Disease control Sponsor: French Africa Pediatric Oncology Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involves 1,000 children with Burkitt's lymphoma, a fast-growing cancer. Researchers want to see if checking children earlier and adjusting treatment based on response can improve outcomes, especially for advanced-stage disease. The goal is to refine treatment recommendations to help more children survive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURKITT LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Burkitt lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURKITT LYMPHOMA

Contacts and locations

Locations

CHU Gabriel Touré (HGT)
RECRUITING

Bamako, Mali
CHU de Treichville à ABIDJAN
RECRUITING

Abidjan, Côte d’Ivoire
Cliniques Universitaires de Kinshasa
RECRUITING

Kinshasa, Kinshasa City, BP 12 KIN XI, Democratic Republic of the Congo
Cliniques Universitaires de Lubumbashi (CUL)
RECRUITING

Lubumbashi, BP 1825, Democratic Republic of the Congo
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
RECRUITING

Antananarivo, BP 4150, Madagascar
Hopital Yalgado Ouedraogo
RECRUITING

Ouagadougou, 03 BP 7022, Burkina Faso
Hôpital Aristide Le Dantec
RECRUITING

Dakar, BP 3001, Senegal

More trials for these conditions

Other studies related to the condition(s) this trial covers.